PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Macrogol compound - Constipation

PAD Profile : Macrogol compound - Constipation

Keywords :
laxatives
Brand Names Include :
Laxido, Movicol, Cosmocol, Macilax, Molaxole, Strigol

Traffic Light Status

Status 1 of 1.

Status :
Green
Important
Formulations :
  • Sachets (powder)
Important Information :
Prescribe as macrogol compound oral powder sachets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
03 July 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands APC have adopted the CKS principles for the management of constipation in adults.

Management | Constipation | CKS | NICE

The CKS guidance covers the management of constipation in adults (including pregnant women and those who are breastfeeding), for short-duration and chronic constipation, and faecal loading and/or impaction.

Refer to the formulary for Traffic Light status / place in therapy of locally agreed treatment options.

02 October 2019
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

GENERIC macrogol compound has been considered by the APC and has been assigned a GREEN traffic light status.

NOTE - the branded product, Movicol, was considered NON-FORMULARY at the APC in May 2017

Associated BNF Codes

01. Gastro-Intestinal System
01.06.04. Osmotic laxatives
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More